financetom
Business
financetom
/
Business
/
Westaim Q2 Net Loss Narrows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Westaim Q2 Net Loss Narrows
Aug 22, 2025 4:19 AM

07:14 AM EDT, 08/22/2025 (MT Newswires) -- The Westaim Corporation ( WEDXF ) , an integrated insurance and alternative asset management company, overnight Thursday reported a smaller loss in the second quarter.

For the three-months ended June 30, the company reported a narrowed net loss attributable to controlling interests of $0.2 million compared with $17.1 million a year earlier.

Revenue for the quarter increased to $10.5 million, compared with $3.5 million, a year-ago.

"As expected, Westaim's ( WEDXF ) Q2 2025 was populated by substantial accounting activity, with significant one-time expenses and non-cash gains associated with the implementation of the new business strategy," said Westaim ( WEDXF ) Chief Executive Cameron MacDonald. "Notably, Ceres Life has secured necessary licenses, approvals, and received its AM Best Financial Strength Rating of B++. They will officially launch in the first week in September with their distribution partner, Advisors Excel."

Shares of the company closed up 0.4% at $28.6 on Thursday on the TSX Venture Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Parsons to Manage Vermont Air National Guard's Groundwater Treatment System
Parsons to Manage Vermont Air National Guard's Groundwater Treatment System
Oct 4, 2024
04:42 PM EDT, 10/03/2024 (MT Newswires) -- Parsons (PSN) said late Thursday that the National Guard Bureau selected the company to manage the operation and maintenance of a groundwater treatment system at Burlington Air National Guard Base, Vermont. The two-year task order for the per-and polyfluoroalkyl substances system is new work for the company, it said without disclosing the contract's...
Upstart Holdings Insider Sold Shares Worth $1,419,673, According to a Recent SEC Filing
Upstart Holdings Insider Sold Shares Worth $1,419,673, According to a Recent SEC Filing
Oct 4, 2024
04:33 PM EDT, 10/03/2024 (MT Newswires) -- Paul Gu, Director, Chief Technology Offier, on October 01, 2024, sold 36,200 shares in Upstart Holdings ( UPST ) for $1,419,673. Following the Form 4 filing with the SEC, Gu has control over a total of 878,565 shares of the company, with 878,565 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1647639/000162828024042156/xslF345X05/wk-form4_1727987268.xml Price: 38.87, Change: -0.07,...
BRIEF-Martin Midstream Partners L.P. To Be Acquired By Martin Resource Management Corporation
BRIEF-Martin Midstream Partners L.P. To Be Acquired By Martin Resource Management Corporation
Oct 4, 2024
Martin Midstream Partners LP ( MMLP ): * MARTIN MIDSTREAM PARTNERS L.P. ( MMLP ) TO BE ACQUIRED BY MARTIN RESOURCE MANAGEMENT CORPORATION * MARTIN MIDSTREAM PARTNERS LP ( MMLP ): PROPOSED DEAL FOR ALL-CASH TRANSACTION OF $4.02 PER COMMON UNIT * MARTIN MIDSTREAM PARTNERS LP ( MMLP ) - MRMC TO FUND MERGER THROUGH CASH, CREDIT FACILITY, AND MANAGEMENT...
Summit Therapeutics Completes Enrollment in Phase 3 Lung Cancer Drug Study
Summit Therapeutics Completes Enrollment in Phase 3 Lung Cancer Drug Study
Oct 4, 2024
04:39 PM EDT, 10/03/2024 (MT Newswires) -- Summit Therapeutics ( SMMT ) said late Thursday it has completed enrollment in its late-stage HARMONi clinical trial from sites in North America, Europe, and China, with topline data expected in mid-2025. The study is evaluating ivonescimab plus platinum-doublet chemotherapy against placebo plus platinum-doublet chemotherapy with epidermal growth factor receptor-mutated, locally advanced or...
Copyright 2023-2026 - www.financetom.com All Rights Reserved